Large-scale testing (Phase 3)Study completedNCT03860935
What this trial is testing
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Who this might be right for
AmyloidosisAmyloid CardiomyopathyTransthyretin Amyloidosis+2 more
Eidos Therapeutics, a BridgeBio company 632